Accelerate Diagnostics, Inc. (AXDX)
Largest Insider Buys in Sector
AXDX Stock Price History Chart
AXDX Stock Performance
About Accelerate Diagnostics, Inc.
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic …
Insider Activity of Accelerate Diagnostics, Inc.
Over the last 12 months, insiders at Accelerate Diagnostics, Inc. have bought $219,998 and sold $87,223 worth of Accelerate Diagnostics, Inc. stock.
On average, over the past 5 years, insiders at Accelerate Diagnostics, Inc. have bought $10M and sold $471,910 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Strobeck Matthew (director) — $450,000. MASSARANY HANY (director) — $49,998. PATIENCE JOHN (director) — $49,998.
The last purchase of 16,666 shares for transaction amount of $24,999 was made by PATIENCE JOHN (director) on 2024‑01‑23.
List of Insider Buy and Sell Transactions, Accelerate Diagnostics, Inc.
| 2024-05-20 | Sale | Chief Technology Officer | 361 0.0016% | $0.88 | $318 | +74.27% | ||
| 2024-04-17 | Sale | Chief Executive Officer | 26,735 0.1307% | $0.78 | $20,853 | +88.32% | ||
| 2024-04-12 | Sale | Chief Executive Officer | 26,545 0.1187% | $0.86 | $22,829 | +55.87% | ||
| 2024-04-09 | Sale | Chief Technology Officer | 13,984 0.0653% | $0.87 | $12,166 | +55.49% | ||
| 2024-04-09 | Sale | Chief Financial Officer | 13,296 0.0621% | $0.87 | $11,568 | +55.49% | ||
| 2024-04-04 | Sale | Chief Executive Officer | 15,887 0.0821% | $0.88 | $13,981 | +58.35% | ||
| 2024-04-04 | Sale | Chief Technology Officer | 978 0.0051% | $0.88 | $861 | +58.35% | ||
| 2024-02-26 | Sale | Chief Financial Officer | 350 0.0016% | $0.96 | $336 | +30.21% | ||
| 2024-02-01 | Sale | Chief Executive Officer | 494 0.0024% | $1.30 | $642 | -1.22% | ||
| 2024-01-23 | director | 16,666 0.1274% | $1.50 | $24,999 | -6.82% | |||
| 2024-01-23 | director | 100,000 0.7643% | $1.50 | $150,000 | -6.82% | |||
| 2024-01-23 | director | 16,666 0.1274% | $1.50 | $24,999 | -6.82% | |||
| 2024-01-23 | director | 13,333 0.1019% | $1.50 | $20,000 | -6.82% | |||
| 2023-12-13 | Sale | Chief Executive Officer | 739 0.0048% | $4.39 | $3,244 | -72.29% | ||
| 2023-12-13 | Sale | Chief Financial Officer | 97 0.0006% | $4.39 | $426 | -72.29% | ||
| 2023-10-13 | Sale | Chief Executive Officer | 734 0.0051% | $5.83 | $4,279 | -77.38% | ||
| 2023-10-13 | Sale | Chief Financial Officer | 96 0.0007% | $5.83 | $560 | -77.38% | ||
| 2023-09-13 | Sale | Chief Executive Officer | 733 0.0052% | $6.53 | $4,786 | -78.74% | ||
| 2023-09-13 | Sale | Chief Financial Officer | 96 0.0007% | $6.53 | $627 | -78.74% | ||
| 2023-08-14 | Sale | Chief Executive Officer | 751 0.0049% | $6.80 | $5,107 | -81.08% |
Insider Historical Profitability
| PATIENCE JOHN | director | 453224 1.8097% | $1.68 | 11 | 0 | +24.1% |
| Strobeck Matthew | director | 120682 0.4819% | $1.68 | 8 | 0 | +26.67% |
| Mertz Larry Michael | Chief Technology Officer | 81831 0.3268% | $1.68 | 2 | 5 | <0.0001% |
| MASSARANY HANY | director | 24260 0.0969% | $1.68 | 3 | 0 | <0.0001% |
| FRANCESCONI LOUISE | director | 20927 0.0836% | $1.68 | 1 | 0 |
Institutional Investor Ownership
| Armistice Capital Llc | $1.83M | 8.37 | 1.85M | New | +$1.83M | 0.01 | |
| Griffin Asset Management Inc | $1.34M | 6.14 | 1.35M | +11.03% | +$133,184.65 | 0.16 | |
| Birchview Capital Lp | $321,986.00 | 1.48 | 325,239 | +44.4% | +$98,999.81 | 0.02 | |
| The Vanguard Group | $311,884.00 | 1.43 | 315,034 | +2.74% | +$8,313.04 | <0.0001 | |
| Geode Capital Management | $129,300.00 | 0.59 | 130,593 | +50.1% | +$43,158.42 | <0.0001 |